Cargando…
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)
Autores principales: | Bar-Or, Amit, Pender, Michael P., Khanna, Rajiv, Steinman, Lawrence, Hartung, Hans-Peter, Maniar, Tap, Croze, Ed, Aftab, Blake T., Giovannoni, Gavin, Joshi, Manher A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445335/ https://www.ncbi.nlm.nih.gov/pubmed/33608230 http://dx.doi.org/10.1016/j.molmed.2021.01.004 |
Ejemplares similares
-
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
por: Bar-Or, Amit, et al.
Publicado: (2020) -
Molecular signature of Epstein-Barr virus infection in MS brain lesions
por: Moreno, Monica A., et al.
Publicado: (2018) -
Epstein-Barr–negative MS: a true phenomenon?
por: Dobson, Ruth, et al.
Publicado: (2017) -
Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014) -
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
por: Pender, Michael P., et al.
Publicado: (2020)